Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4-week randomized double-blind placebo-controlled trial of AZD1981 in persistent asthma
2006-001193-25Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing AZD1981 twice daily with Placebo (2 arms). Primary endpoint: Primary clinical efficacy endpoint. Started Apr 2006; status: completed.
02
Drugs
timapiprant
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-001193-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001193-25.